Diltiazem Hydrochloride
NDC 24979-182, diltiazem hydrochloride, capsule, extended release, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 24979-182
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217377
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-182 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DILTIAZEM HYDROCHLORIDE90 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-182-01 | 24979018201 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (24979-182-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f276d9fe-a685-4d99-ad82-d4452ef4ba98NADAC price for package 24979018201
GET /v1/drugs/nadac/24979018201
Use it
Look up 24979-182 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-182 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-182. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.